The results of a landmark study published this month in Circulation indicate that a new device from Medtronic (Minneapolis), the IN.PACT Admiral drug-coated balloon (DCB) significantly outperformed standard balloon angioplasty in the treatment of symptomatic peripheral artery disease in the upper leg, specifically the superficial femoral and proximal popliteal arteries.